Managed Account Advisors’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Managed Account Advisors’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-28	Closed	-$5K	–	3216
2015 Q1	$5K	Sell	28 -79,778	-100%	-$11.7M	﹤0.01%	2881
2014 Q4	$9.17M	Sell	79,806 -40,292	-34%	-$4.88M	0.01%	1082
2014 Q3	$18.8M	Sell	120,098 -16,795	-12%	-$2.43M	0.02%	714
2014 Q2	$16.9M	Buy	136,893 +54,416	+66%	+$6.01M	0.02%	755
2014 Q1	$8.54M	Sell	82,477 -70,154	-46%	-$7.18M	0.01%	1049
2013 Q4	$13.7M	Sell	152,631 -28,186	-16%	-$2.25M	0.02%	810
2013 Q3	$12.1M	Sell	180,817 -76,387	-30%	-$5.26M	0.02%	817
2013 Q2	$17M	Buy	+257,204	New	+$14.7M	0.03%	647

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $487M AUM 49.37% 1-Year Est. Return

Managed Account Advisors's SLXP Position: Q2 2015 in Review

Managed Account Advisors sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 28 shares — an estimated $5K sold.

Managed Account Advisors first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $18.8M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Managed Account Advisors reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Managed Account Advisors sold 28 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $5K.
Managed Account Advisors first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Managed Account Advisors's SALIX PHARMACEUTICALS LTD DEL position peaked at $18.8M in Q3 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.